KRAS and colorectal carcinoma: The results show that the KRAS mutant CRC cell proliferation rate significantly decreased with reduced concentration of (0.5 mm) glutamine, whereas the KRAS wt CRC cell lines exhibit a less significant dependence on extracellular glutamine (Fig. S1A).